The effect of intravenous L-tryptophan on prolactin and growth hormone and mood in healthy subjects

Psychopharmacology

Volumn 77, Issue 3, 1982, Pages 217-222

  Charney, Dennis S ^a,b   Heninger, George R ^a,b   Reinhard Jr , John F ^a,b   Sternberg, David E ^a,b   Hafstead, Karen M ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Yale University School of Medicine   (United States)

Author keywords

Growth hormone; Mood; Prolactin; Serotonin; Tryptophan

Indexed keywords

GROWTH HORMONE; PLACEBO; PROLACTIN; SEROTONIN; TRYPTOPHAN;

ADVERSE DRUG REACTION; CENTRAL NERVOUS SYSTEM; ENDOCRINE SYSTEM; HORMONE RELEASE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MOOD; NORMAL HUMAN; RADIOIMMUNOASSAY;

5-HYDROXYTRYPTOPHAN; ADULT; BRAIN CHEMISTRY; EMOTIONS; FEMALE; GROWTH HORMONE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROLACTIN; SEROTONIN; TIME FACTORS; TRYPTOPHAN;

EID: 0019957419     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF00464569     Document Type: Article

References (66)

1. Serotonergic control of prolactin release in male rats
2. Hypersensitive serotonin receptors involved in clinical depression — a theory
3. L-Tryptophan injection enhances pulsatile growth hormone secretion in the rat
4. Failure of oral 5-hydroxytryptophan to affect prolactin secretion in man
5. Catecholamine inhibition of prolactin secretion by isolated rat adenohypophyses
6. Hyperphagia and obesity following serotonin depletion by intraventricular para-chlorophenylalanine
7. Receptor sensitivity and the mechanism of action of antidepressant treatment: Implications for the etiology and therapy of depression
8. Evidence that serotonin neurons stimulate secretion of prolactin releasing factor
9. Further evidence that serotonin is a neurotransmitter involved in prolactin secretion
10. Tricyclic antidepressants: long term treatment increases responsivity of rat forebrain neurons to serotonin
11. Canine growth hormone responsiveness during pentobarbital anesthesia: a method for evaluating serotonergic stimulatory action
12. Effect of tryptophan administration on 5HIAA in cerebrospinal fluid in man
13. Role of biogenic amines in aggressive behavior
14. Lack of effects of L-tryptophan on basal and TRH-stimulated TSH and prolactin levels
15. Brain serotonin content: Physiological dependence on plasma tryptophan levels
16. Effect of electrolytic lesions of the medial raphe nucleus on 5-HTP and LU 10-171 induced increases in serum prolactin in rats
17. Effect of L-tryptophan on growth hormone and prolactin release in normal volunteers and patients with secretory pituitary tumors
18. Enhanced serotonin receptor activity after chronic treatment with imipramine or amitriptyline
19. DL-5-Hydroxytryptophan-induced changes in central monoamine neurons after peripheral decarboxylase inhibition
20. On the mechanism of action of the antidepressant drugs amitriptyline and nortriptyline. Evidence for 5-hydroxytryptamine receptor blocking activity
21. Evidence that serotonin stimulates a prolactin-releasing factor in the rat
22. Stimulatory role for brain serotonergic system on prolactin secretion in the male rat
23. Absent growth hormone response to L-tryptophan in acromegaly
24. Absent prolactin response to L-tryptophan in normal and acromegalic subjects
25. Effects of drugs on processes regulating the functional activity of brain 5-hydroxytryptamine
26. The acute effects of intravenous infusion of L-tryptophan in normal subjects
27. The acute effects of oral tryptophan in human subjects
28. Failure of 5-hydroxytryptophan to stimulate prolactin and growth hormone secretion on man
29. L-Tryptophan and neuroendocrine regulation in neurologic patients: Hormone responses to L-tryptophan loading in patients with hypothalamic lesions
30. L-Tryptophan treatment and the episodic secretion of pituitary hormones and cortisol
31. Effect of 5-hydroxytryptophan (5HTP) on growth hormone and ACTH release in man
32. Enhancement of 5-hydroxytryptamine-induced behavioral effects following chronic administration of antidepressant drugs
33. Biogenic amines and states of sleep
34. Effect of melatonin and serotonin on the release of FSH and prolactin
35. Effect of 5-hydroxytryptophan (5-HTP) on plasma prolactin levels in man
36. Participation of serotonin containing neurons in the suckling-induced rise in plasma prolactin levels in lactating rats
37. The interaction of serotonergic and dopaminergic systems on prolactin secretion in the rat
38. Effect of L-5-hydroxytryptophan infusion on growth hormone and prolactin secretion in man
39. Uptake of 5-hydroxytryptamine and 5-hydroxytryptophan by neurons of the central nervous system normally containing catecholamines
40. Stimulation of human prolactin secretion by intravenous infusion of L-tryptophan
41. Central antiserotonin action of amitryptoline
42. The antiserotonin actions of Mianserin
43. Role of biogenic amines in control of anterior pituitary hormones
44. Hypothalamic hypophysiotropic hormones and neurotransmitter regulation: current views
45. Effect of quipazine on rat plasma prolactin levels
46. Suppression of sleep-related prolactin secretion and enhancement of sleep-related growth hormone secretion
47. Chronic antidepressant treatment enhances α-adrenergic and serotonergic responses in the facial nucleus
48. Serotonin-containing neurons: Their possible role in pain and analgesia
49. Mianserin, danitracen and amitriptyline withdrawal increases the behavioral responses of rats to L-5-HTP
50. The effects of precursor loading in the cerebral metabolism of 5-hydroxyindoles
51. Effect of L-tryptophan and restraint stress on hypothalamine and brain serotonin turnover, and pituitary TSH and prolactin release in rats
52. Slight effect of L-tryptophan on growth hormone release in normal human subjects
53. Current status of the indoleamine hypothesis of affective disorders
54. Control of body temperature in the unanesthesized monkey by cholinergic and aminergic systems in the hypothalamus
55. Release of (3H) dopamine by L-5-hydroxytryptophan
56. Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs
57. Effect of hypothalamine surgery on prolactin release induced by 5-hydroxytryptophan (5-HTP) in rats
58. Some experiments in the chemistry of normal sleep
59. Chronic antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding
60. Mood elevation and pituitary stimulation after IV L-5-HTP in normal subjects: Evidence for a common serotonergic mechanism
61. A sensitive double antibody immunoassay for human growth hormone in plasma
62. A homologous radioimmunoassay for human prolactin
63. Central nervous system effects of ingestion of L-tryptophan by normal subjects
64. Serotoninergic control of human growth hormone secretion: The actions of L-dopa and 2-bromoergocrytise
65. Monoamines and histamine in regulation of anterior pituitary secretion
66. Effect of serotonin precursor, tryptophan, on pituitary hormone secretion